TR
Therapeutic Areas
Arpeggio Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| NRF2 Program | Lung Cancer (implied) | Pre-clinical |
| Transcriptomic Screening Platform | Oncology & Beyond | Discovery |
Leadership Team at Arpeggio Biosciences
JA
Joey Azofeifa, PhD
CEO & Co-founder
SG
Stefan Gross, PhD
Chief Scientific Officer
AR
Andy Ren, PhD
Head of Drug Discovery